|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/6886 | (2018.01) |
| C12Q 1/6886 | (2013.01) | ||
| C12Q2600/118 | (2013.01) | ||
| C12Q2600/156 | (2013.01) |
| (11) | Number of the document | 3788173 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19724365.2 |
| Date of filing the European patent application | 2019-05-03 | |
| (97) | Date of publication of the European application | 2021-03-10 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2019/061328 |
| Date | 2019-05-03 |
| (87) | Number | WO 2019/211418 |
| Date | 2019-11-07 |
| (30) | Number | Date | Country code |
| 201862666329 P | 2018-05-03 | US |
| (72) |
BALASUBRAMANYAM, Aarthi , US
JU, Christine , US
MA, Xiaoju , US
MULEY, Thomas , DE
HERTH, Felix , DE
TIKOO, Nalin , US
WEHNL, Birgit , DE
XI, Liu , US
YAUNG, Stephanie J. , US
PATI, Amrita , US
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
Roche Diagnostics GmbH , Sandhofer Straße 116, 68305 Mannheim, DE |
| (54) | SURROGATE MARKER AND METHOD FOR TUMOR MUTATION BURDEN MEASUREMENT |
| SURROGATE MARKER AND METHOD FOR TUMOR MUTATION BURDEN MEASUREMENT |